Analyst Ratings for Companhia Brasileira de Distribuicao Grupo Pao de Acucar ADR (CBD)Updated: 2017-07-27
Companhia Brasileira de Distribuicao Grupo Pao de Acucar ADR (NYSE:CBD) was awarded an average rating of Overweight from investment analysts following the stock. A consensus rating of Overweight was previously issued for CBD last month.
A buy rating was issued by 8 analysts, 0 gave an overweight rating, 6 issued a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. Meanwhile, the number of analysts pessimistic about the company has increased by 0.
Investment analysts gave a few price targets for CBD. The most optimistic price target was 27.88, implying potential capital gains of 22.77 percent. The most pessimistic analyst gave a price target of 21.17, implying potential capital losses of -6.78 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.
Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 250 percent. The average change in earnings estimates over the last 90 days is 0 percent. On the other hand, earnings estimates for the fiscal year have been revised downwards by -0.94 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.14 percent.
Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 1 analysts increased their quarterly estimates, while 0 analysts made negative revisions. During this time, 1 analysts made positive revisions in their estimates for this fiscal year's earnings, while 2 analysts decreased their estimates.
CBD has a 52-week high of 24.75 and a 52-week low of 14.08. The current market price is above the trailing year's low by 61.29 percent, and below the high by 8.24 percent. CBD has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The CBD value stock report compares CBD to some of its peers using value stock charts. The stock has a market capitalization of $5.18 billion. CBD will post this quarters earnings in days, on 0000-00-00.